Background and Objective: Vision impairment caused by cataracts impacts patients’ daily activities, affecting their quality of life. This study aims to assess patients’ quality of life after cataract surgery using the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25). Method: Participants were patients who had undergone cataract surgery at Yaounde Gyneco-Obstetrics and Pediatrics Hospital (HGOPY) and Essos Medico-Surgical Center between September 1, 2018, and May 31, 2019. Participants were evaluated preoperatively, 14 days after cataract surgery, and one month after cataract surgery.
Background: To compare central corneal thickness (CCT) values measured in diabetic eyes and compare the CCT values in normal patients without diabetes. Methods: A total of 83 diabetic patients and 83 non-diabetic patients were prospectively enrolled in this comparative case series. CCT was measured using a Topcon CT-1P non-contact automated pachymeter, and values were compared. Results: Mean age was 57 ± 11 years, with a range of 23 and 80 years. The mean CCT was 508.87 ± 35.83 µm for diabetic patients and 513.41 ± 37.22 µm for non-diabetic patients. There was no statistically significant difference between the CCT of diabetic patients compared to non-diabetic patients (p = 0.260). We did not find a significant correlation between the CCT of diabetic patients and clinical characteristics of diabetes. However, there was a positive and statistically significant linear correlation between the CCT of diabetic patients and intra ocular pressure (IOP). Conclusion: The mean CCT in diabetic patients was lower than in non-diabetic control patients, although there was no statistically significant difference.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.